Gefitinib.

Rawluk, Justyna; Waller, Cornelius F

Gefitinib.

Rawluk, Justyna; Waller, Cornelius F.

Affiliation

Rawluk J; Department of Haematology, Oncology and Stem Cell Transplantation, University Medical Centre Freiburg, Faculty of Medicine, University of Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany.
Waller CF; Department of Haematology, Oncology and Stem Cell Transplantation, University Medical Centre Freiburg, Faculty of Medicine, University of Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany. cornelius.waller@uniklinik-freiburg.de.

Recent Results Cancer Res ; 211: 235-246, 2018.

Article in En | MEDLINE | ID: mdl-30069771

Subject(s)

Antineoplastic Agents/pharmacology; Carcinoma, Non-Small-Cell Lung/drug therapy; Lung Neoplasms/drug therapy; Protein Kinase Inhibitors/pharmacology; Quinazolines/pharmacology; Animals; ErbB Receptors/antagonists & inhibitors; Gefitinib; Humans

Key words

EGFR mutation; Epidermal growth factor receptor (EGFR); Gefitinib; Non-small cell lung cancer; Tyrosine kinase inhibitor (TKI)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Quinazolines / Carcinoma, Non-Small-Cell Lung / Protein Kinase Inhibitors / Lung Neoplasms / Antineoplastic Agents Type of study: Clinical_trials Limits: Animals / Humans Language: En Journal: Recent Results Cancer Res Year: 2018 Type: Article Affiliation country: Germany

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google